Connect with us

Public Companies

Champignon Brands Renames to Braxia Scientific to Reflect Integration of Ketamine & Psychedelic Clinics in its R&D Priorities

The post Champignon Brands Renames to Braxia Scientific to Reflect Integration of Ketamine & Psychedelic Clinics in its R&D Priorities appeared…

Published

on

Champignon’s Familiar SHRM Ticker Will Change to BRAX as it Resumes Trading on the CSE

The company’s familiar ticker symbol will change from SHRM to BRAX as it continues trading on the Canadian Securities Exchange. The name change spotlights not only their standard of care in ketamine therapy but the future of psychedelic derivatives and next-generation mental health therapy to come.

champignon brands braxia scientific rebrand name change

CEO Projects Path Forward in Drug Development With Large International Pharmaceutical Companies

Their CEO, Roger McIntyre, was quoted in the press release stating that their name change allows them to “emphasize [their] core business objective around changing the way depression and other mental disorders are treated through [their] growing network of clinics.” He went on to state their intention to get involved in research and drug development has been a hallmark of their brand and that they are well-positioned to do so. He believes that they can set the standard of care that will ensure the best outcome for patients with depression across the globe.

champignon brands braxia scientific rebrand name change

The Company Also Released Common Shares Owed for R&D Services

A good sign for anyone in the drug development game is R&D spending, and that’s exactly what Champignon, now Braxia, is doing. The release stated that the company is issuing 250,000 common shares to settle a debt of $125,000 to an independent contractor for R&D services. Evidence-based medical solutions are a hot commodity in modern psychedelic drug development and there is no shortage of capital either. The most promising plays lean heavily into R&D spending, so this is a good sign. Investors and psychedelic enthusiasts will surely be keeping an eye out on this dynamic brand to see what developments come next.  

The post Champignon Brands Renames to Braxia Scientific to Reflect Integration of Ketamine & Psychedelic Clinics in its R&D Priorities appeared first on Microdose Psychedelic Insights.

Read More

Trending